The Outsourcing in Drug Development market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Outsourcing in Drug Development size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Outsourcing in Drug Development market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Outsourcing in Drug Development market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Clinical Trials
New Drug Application
Market segment by Application, can be divided into
Pharmaceutical Industries
Biotechnology Industries
Medical Device Industries
Market segment by players, this report covers
Charles River Laboratories
Covance
ICON
Parexel
Quintiles Transnational
PPD
PRA Health Sciences
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Outsourcing in Drug Development
1.2 Classification of Outsourcing in Drug Development by Type
1.2.1 Overview: Global Outsourcing in Drug Development Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Outsourcing in Drug Development Revenue Market Share by Type in 2020
1.2.3 Clinical Trials
1.2.4 New Drug Application
1.3 Global Outsourcing in Drug Development Market by Application
1.3.1 Overview: Global Outsourcing in Drug Development Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Pharmaceutical Industries
1.3.3 Biotechnology Industries
1.3.4 Medical Device Industries
1.4 Global Outsourcing in Drug Development Market Size & Forecast
1.5 Global Outsourcing in Drug Development Market Size and Forecast by Region
1.5.1 Global Outsourcing in Drug Development Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Outsourcing in Drug Development Market Size by Region, (2016-2021)
1.5.3 North America Outsourcing in Drug Development Market Size and Prospect (2016-2026)
1.5.4 Europe Outsourcing in Drug Development Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Outsourcing in Drug Development Market Size and Prospect (2016-2026)
1.5.6 South America Outsourcing in Drug Development Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Outsourcing in Drug Development Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Outsourcing in Drug Development Market Drivers
1.6.2 Outsourcing in Drug Development Market Restraints
1.6.3 Outsourcing in Drug Development Trends Analysis
2 Company Profiles
2.1 Charles River Laboratories
2.1.1 Charles River Laboratories Details
2.1.2 Charles River Laboratories Major Business
2.1.3 Charles River Laboratories Outsourcing in Drug Development Product and Solutions
2.1.4 Charles River Laboratories Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Charles River Laboratories Recent Developments and Future Plans
2.2 Covance
2.2.1 Covance Details
2.2.2 Covance Major Business
2.2.3 Covance Outsourcing in Drug Development Product and Solutions
2.2.4 Covance Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Covance Recent Developments and Future Plans
2.3 ICON
2.3.1 ICON Details
2.3.2 ICON Major Business
2.3.3 ICON Outsourcing in Drug Development Product and Solutions
2.3.4 ICON Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 ICON Recent Developments and Future Plans
2.4 Parexel
2.4.1 Parexel Details
2.4.2 Parexel Major Business
2.4.3 Parexel Outsourcing in Drug Development Product and Solutions
2.4.4 Parexel Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Parexel Recent Developments and Future Plans
2.5 Quintiles Transnational
2.5.1 Quintiles Transnational Details
2.5.2 Quintiles Transnational Major Business
2.5.3 Quintiles Transnational Outsourcing in Drug Development Product and Solutions
2.5.4 Quintiles Transnational Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Quintiles Transnational Recent Developments and Future Plans
2.6 PPD
2.6.1 PPD Details
2.6.2 PPD Major Business
2.6.3 PPD Outsourcing in Drug Development Product and Solutions
2.6.4 PPD Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 PPD Recent Developments and Future Plans
2.7 PRA Health Sciences
2.7.1 PRA Health Sciences Details
2.7.2 PRA Health Sciences Major Business
2.7.3 PRA Health Sciences Outsourcing in Drug Development Product and Solutions
2.7.4 PRA Health Sciences Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 PRA Health Sciences Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Outsourcing in Drug Development Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Outsourcing in Drug Development Players Market Share
3.2.2 Top 10 Outsourcing in Drug Development Players Market Share
3.2.3 Market Competition Trend
3.3 Outsourcing in Drug Development Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Outsourcing in Drug Development Revenue and Market Share by Type (2016-2021)
4.2 Global Outsourcing in Drug Development Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Outsourcing in Drug Development Revenue Market Share by Application (2016-2021)
5.2 Outsourcing in Drug Development Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Outsourcing in Drug Development Revenue by Type (2016-2026)
6.2 North America Outsourcing in Drug Development Revenue by Application (2016-2026)
6.3 North America Outsourcing in Drug Development Market Size by Country
6.3.1 North America Outsourcing in Drug Development Revenue by Country (2016-2026)
6.3.2 United States Outsourcing in Drug Development Market Size and Forecast (2016-2026)
6.3.3 Canada Outsourcing in Drug Development Market Size and Forecast (2016-2026)
6.3.4 Mexico Outsourcing in Drug Development Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Outsourcing in Drug Development Revenue by Type (2016-2026)
7.2 Europe Outsourcing in Drug Development Revenue by Application (2016-2026)
7.3 Europe Outsourcing in Drug Development Market Size by Country
7.3.1 Europe Outsourcing in Drug Development Revenue by Country (2016-2026)
7.3.2 Germany Outsourcing in Drug Development Market Size and Forecast (2016-2026)
7.3.3 France Outsourcing in Drug Development Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Outsourcing in Drug Development Market Size and Forecast (2016-2026)
7.3.5 Russia Outsourcing in Drug Development Market Size and Forecast (2016-2026)
7.3.6 Italy Outsourcing in Drug Development Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Outsourcing in Drug Development Revenue by Type (2016-2026)
8.2 Asia-Pacific Outsourcing in Drug Development Revenue by Application (2016-2026)
8.3 Asia-Pacific Outsourcing in Drug Development Market Size by Region
8.3.1 Asia-Pacific Outsourcing in Drug Development Revenue by Region (2016-2026)
8.3.2 China Outsourcing in Drug Development Market Size and Forecast (2016-2026)
8.3.3 Japan Outsourcing in Drug Development Market Size and Forecast (2016-2026)
8.3.4 South Korea Outsourcing in Drug Development Market Size and Forecast (2016-2026)
8.3.5 India Outsourcing in Drug Development Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Outsourcing in Drug Development Market Size and Forecast (2016-2026)
8.3.7 Australia Outsourcing in Drug Development Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Outsourcing in Drug Development Revenue by Type (2016-2026)
9.2 South America Outsourcing in Drug Development Revenue by Application (2016-2026)
9.3 South America Outsourcing in Drug Development Market Size by Country
9.3.1 South America Outsourcing in Drug Development Revenue by Country (2016-2026)
9.3.2 Brazil Outsourcing in Drug Development Market Size and Forecast (2016-2026)
9.3.3 Argentina Outsourcing in Drug Development Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Outsourcing in Drug Development Revenue by Type (2016-2026)
10.2 Middle East & Africa Outsourcing in Drug Development Revenue by Application (2016-2026)
10.3 Middle East & Africa Outsourcing in Drug Development Market Size by Country
10.3.1 Middle East & Africa Outsourcing in Drug Development Revenue by Country (2016-2026)
10.3.2 Turkey Outsourcing in Drug Development Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Outsourcing in Drug Development Market Size and Forecast (2016-2026)
10.3.4 UAE Outsourcing in Drug Development Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Outsourcing in Drug Development Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Outsourcing in Drug Development Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Outsourcing in Drug Development Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Outsourcing in Drug Development Revenue (USD Million) by Region (2016-2021)
Table 5. Global Outsourcing in Drug Development Revenue Market Share by Region (2021-2026)
Table 6. Charles River Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Charles River Laboratories Major Business
Table 8. Charles River Laboratories Outsourcing in Drug Development Product and Solutions
Table 9. Charles River Laboratories Outsourcing in Drug Development Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Covance Corporate Information, Head Office, and Major Competitors
Table 11. Covance Major Business
Table 12. Covance Outsourcing in Drug Development Product and Solutions
Table 13. Covance Outsourcing in Drug Development Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. ICON Corporate Information, Head Office, and Major Competitors
Table 15. ICON Major Business
Table 16. ICON Outsourcing in Drug Development Product and Solutions
Table 17. ICON Outsourcing in Drug Development Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Parexel Corporate Information, Head Office, and Major Competitors
Table 19. Parexel Major Business
Table 20. Parexel Outsourcing in Drug Development Product and Solutions
Table 21. Parexel Outsourcing in Drug Development Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Quintiles Transnational Corporate Information, Head Office, and Major Competitors
Table 23. Quintiles Transnational Major Business
Table 24. Quintiles Transnational Outsourcing in Drug Development Product and Solutions
Table 25. Quintiles Transnational Outsourcing in Drug Development Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. PPD Corporate Information, Head Office, and Major Competitors
Table 27. PPD Major Business
Table 28. PPD Outsourcing in Drug Development Product and Solutions
Table 29. PPD Outsourcing in Drug Development Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. PRA Health Sciences Corporate Information, Head Office, and Major Competitors
Table 31. PRA Health Sciences Major Business
Table 32. PRA Health Sciences Outsourcing in Drug Development Product and Solutions
Table 33. PRA Health Sciences Outsourcing in Drug Development Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Outsourcing in Drug Development Revenue (USD Million) by Players (2019-2021)
Table 35. Global Outsourcing in Drug Development Revenue Share by Players (2019-2021)
Table 36. Breakdown of Outsourcing in Drug Development by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Outsourcing in Drug Development Players Head Office, Products and Services Provided
Table 38. Outsourcing in Drug Development Mergers & Acquisitions in the Past Five Years
Table 39. Outsourcing in Drug Development New Entrants and Expansion Plans
Table 40. Global Outsourcing in Drug Development Revenue (USD Million) by Type (2016-2021)
Table 41. Global Outsourcing in Drug Development Revenue Share by Type (2016-2021)
Table 42. Global Outsourcing in Drug Development Revenue Forecast by Type (2021-2026)
Table 43. Global Outsourcing in Drug Development Revenue by Application (2016-2021)
Table 44. Global Outsourcing in Drug Development Revenue Forecast by Application (2021-2026)
Table 45. North America Outsourcing in Drug Development Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Outsourcing in Drug Development Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Outsourcing in Drug Development Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Outsourcing in Drug Development Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Outsourcing in Drug Development Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Outsourcing in Drug Development Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Outsourcing in Drug Development Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Outsourcing in Drug Development Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Outsourcing in Drug Development Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Outsourcing in Drug Development Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Outsourcing in Drug Development Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Outsourcing in Drug Development Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Outsourcing in Drug Development Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Outsourcing in Drug Development Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Outsourcing in Drug Development Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Outsourcing in Drug Development Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Outsourcing in Drug Development Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Outsourcing in Drug Development Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Outsourcing in Drug Development Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Outsourcing in Drug Development Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Outsourcing in Drug Development Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Outsourcing in Drug Development Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Outsourcing in Drug Development Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Outsourcing in Drug Development Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Outsourcing in Drug Development Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Outsourcing in Drug Development Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Outsourcing in Drug Development Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Outsourcing in Drug Development Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Outsourcing in Drug Development Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Outsourcing in Drug Development Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Outsourcing in Drug Development Picture
Figure 2. Global Outsourcing in Drug Development Revenue Market Share by Type in 2020
Figure 3. Clinical Trials
Figure 4. New Drug Application
Figure 5. Outsourcing in Drug Development Revenue Market Share by Application in 2020
Figure 6. Pharmaceutical Industries Picture
Figure 7. Biotechnology Industries Picture
Figure 8. Medical Device Industries Picture
Figure 9. Global Outsourcing in Drug Development Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Outsourcing in Drug Development Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Outsourcing in Drug Development Revenue Market Share by Region (2016-2026)
Figure 12. Global Outsourcing in Drug Development Revenue Market Share by Region in 2020
Figure 13. North America Outsourcing in Drug Development Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Outsourcing in Drug Development Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Outsourcing in Drug Development Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Outsourcing in Drug Development Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Outsourcing in Drug Development Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Outsourcing in Drug Development Market Drivers
Figure 19. Outsourcing in Drug Development Market Restraints
Figure 20. Outsourcing in Drug Development Market Trends
Figure 21. Charles River Laboratories Recent Developments and Future Plans
Figure 22. Covance Recent Developments and Future Plans
Figure 23. ICON Recent Developments and Future Plans
Figure 24. Parexel Recent Developments and Future Plans
Figure 25. Quintiles Transnational Recent Developments and Future Plans
Figure 26. PPD Recent Developments and Future Plans
Figure 27. PRA Health Sciences Recent Developments and Future Plans
Figure 28. Global Outsourcing in Drug Development Revenue Share by Players in 2020
Figure 29. Outsourcing in Drug Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 30. Global Top 3 Players Outsourcing in Drug Development Revenue Market Share in 2020
Figure 31. Global Top 10 Players Outsourcing in Drug Development Revenue Market Share in 2020
Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 33. Global Outsourcing in Drug Development Revenue Share by Type in 2020
Figure 34. Global Outsourcing in Drug Development Market Share Forecast by Type (2021-2026)
Figure 35. Global Outsourcing in Drug Development Revenue Share by Application in 2020
Figure 36. Global Outsourcing in Drug Development Market Share Forecast by Application (2021-2026)
Figure 37. North America Outsourcing in Drug Development Sales Market Share by Type (2016-2026)
Figure 38. North America Outsourcing in Drug Development Sales Market Share by Application (2016-2026)
Figure 39. North America Outsourcing in Drug Development Revenue Market Share by Country (2016-2026)
Figure 40. United States Outsourcing in Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Outsourcing in Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Outsourcing in Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Outsourcing in Drug Development Sales Market Share by Type (2016-2026)
Figure 44. Europe Outsourcing in Drug Development Sales Market Share by Application (2016-2026)
Figure 45. Europe Outsourcing in Drug Development Revenue Market Share by Country (2016-2026)
Figure 46. Germany Outsourcing in Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Outsourcing in Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Outsourcing in Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Outsourcing in Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Outsourcing in Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Outsourcing in Drug Development Sales Market Share by Type (2016-2026)
Figure 52. Asia-Pacific Outsourcing in Drug Development Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Outsourcing in Drug Development Revenue Market Share by Region (2016-2026)
Figure 54. China Outsourcing in Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Japan Outsourcing in Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. South Korea Outsourcing in Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. India Outsourcing in Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Southeast Asia Outsourcing in Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Australia Outsourcing in Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South America Outsourcing in Drug Development Sales Market Share by Type (2016-2026)
Figure 61. South America Outsourcing in Drug Development Sales Market Share by Application (2016-2026)
Figure 62. South America Outsourcing in Drug Development Revenue Market Share by Country (2016-2026)
Figure 63. Brazil Outsourcing in Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Argentina Outsourcing in Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Middle East and Africa Outsourcing in Drug Development Sales Market Share by Type (2016-2026)
Figure 66. Middle East and Africa Outsourcing in Drug Development Sales Market Share by Application (2016-2026)
Figure 67. Middle East and Africa Outsourcing in Drug Development Revenue Market Share by Country (2016-2026)
Figure 68. Turkey Outsourcing in Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Saudi Arabia Outsourcing in Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. UAE Outsourcing in Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Methodology
Figure 72. Research Process and Data Source